Latest filing published 08 Jul 2020 for Ferrexpo plc, €13k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +150.0%Entry £1.79 · Close at T+365 £4.46
- +153.8%Entry £1.71 · Close at T+365 £4.35
- -6.9%Entry £1.95 · Close at T+365 £1.82
- -33.7%Entry £2.25 · Close at T+365 £1.49
- -22.9%Entry £2.03 · Close at T+365 £1.56
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Chris Mawe: trading record in brief
Chris Mawe discloses dealings in Ferrexpo plc to RNS (LSE). In total, 16 filings cover trades dated from 12 April 2017 to 7 July 2020.
In open-market terms, that means 14 purchases worth €53k on one side and 2 sales worth €470k on the other. The amount is not disclosed for 2 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2020 to date brings 2 purchases and no sales.
The median purchase comes to €3,299. 11 out of 11 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 9 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 56% of cases, with a median move of +1.5%. This is a record of the past, not a forecast.
Most recently, on 8 July 2020, the filings show an open-market purchase worth €13k in Ferrexpo plc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Chris Mawe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,907 shares@ £1.724766.4% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:3650863-1Canonical exit: 5 Oct 2020 (T+90)
- 3,447 shares@ £1.7533.6% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:3646598-1Canonical exit: 30 Sept 2020 (T+90)
- 3,503 shares@ £1.94527.3% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20190904161734_14214205_20200326185205206_38121-4Canonical exit: 2 Dec 2019 (T+90)
- 2,872 shares@ £2.17216.0% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20190515162044_14075481_20200326185142472_17076-4Canonical exit: 12 Aug 2019 (T+90)
- 100,000 sharesLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20190429095347_14055251_20200326185040803_2180-0Canonical exit: 25 Jul 2019 (T+90)
- 3,117 shares@ £2.01715.7% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20190115171253_13935635_20200326185116240_17233-6Canonical exit: 14 Apr 2019 (T+90)
- 1,489 shares@ £2.036London Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20180928125306_13809215_20200330111445986_729-6Canonical exit: 25 Dec 2018 (T+90)
- 1,434 shares@ £1.9677.1% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20180628152053_13698020_20200330111423257_2092-6Canonical exit: 25 Sept 2018 (T+90)
- 698 shares@ £2.15760.3% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20180425161352_13618691_20200330111351984_4206-5Canonical exit: 15 Jul 2018 (T+90)
- 251 shares@ £3.1010.2% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20180116152654_13498416_20200330111417153_14823-5Canonical exit: 15 Apr 2018 (T+90)
- 92,202 shares@ £2.85186.3% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20170922105937_13372578_20200330131540972_16416
- 257 shares@ £3.0720.2% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20170908145736_13357128_20200330131540149_5938-5Canonical exit: 7 Dec 2017 (T+90)
- 50,000 shares@ £3.13533.1% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20170905131215_13352403_20200330131540009_2851-1
- 481 shares@ £1.73010.3% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20170608091334_13253691_20200330131522147_6603-4Canonical exit: 29 Aug 2017 (T+90)
- 150,000 sharesLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20170504095443_13214225_20200330131530641_3402-0Canonical exit: 31 Jul 2017 (T+90)
- 305 shares@ £1.67820.2% of flowLondon Stock Exchange - Regulated Market: XLONISIN GB00B1XH2C03FCA-NSM:LSE20170412172529_13193003_20200330131459415_9159-4Canonical exit: 11 Jul 2017 (T+90)
16 of 16 declarations